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ABSTRACT 
 
Purpose: To describe and analyse demographics, clinical 
 
features, visual and anatomical outcomes of patients with macula hole 
 
  (MH) treated at Charlotte Maxeke Johannesburg Academic Hospital. 
 
Methods: A retrospective review of pre- and post- operative findings of 39  
 
patients who underwent MH surgery from January 2008 to 30 October 
 
 2012.  
 
Results: 39 patients were enrolled in the study. The mean age was 63 
 
 years.  49% were males and 51% were females. Majority were black, 59%  
 
of the participants. The average duration of symptoms was 12 months. The  
 
median preoperative Best corrected visual acuity (BCVA) was logMar1.0.  
 
At 1month following surgery, only 23 patients had records. The median 
 
 BCVA was logMar1.3. About 60% had the same BCVA, 13% had an 
 
 increase in BCVA and 17% had decreased BCVA. 65% had closed MH and 
 
  35% patients had open MH. At 3 months, 7 patients met the criteria and 
 
 the rest were excluded due to lack of relevant data. 58% had no change in 
 
 BCVA, 28% had improvement in BCVA and 14% had decreased BCVA.  The 
 
 median gain in BCVA between pre-op and 1 month to 3 month visit was 
 
 logMar1.0, 1line improvement. The median pre-operative Inner hole 
 
 diameter (IHD) was 377um and the Basal hole diameter (BHD) was 
 
766um.  86% of patients had closed MH and 14% had open MH. 
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 Conclusion: Best corrected visual acuity and MH improved at 3 months 
 
 following MH surgery in our African population. 
 
 Patients demographics, clinical features and characteristics are similar to 
 
 patients in other studies in different countries. A larger and longer 
 
 duration study would be beneficial. 
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CHAPTER 1: Overview of the study 
 
            1.1 Introduction 
 
This research will provide a brief outline of the study. The 
 
 background, problem statement, aims, objectives and 
 
 research methodology will be described. Background and 
 
 literature review of the subject will be described together 
 
 with the existing research done already on this topic. 
 
Macula hole (MH) is defined as a full thickness defect of 
 
 the retinal tissue involving the fovea. Significant progress 
 
 has been made in the understanding of macula 
 
 hole (MH), including its pathology, natural history and 
 
 management. 
 
Charlotte-Maxeke Johannesburg Academic hospital is a tertiary 
 
 level academic hospital situated within Johannesburg Metro 
 
 District and serves populations of the three Southern districts of 
 
 the province: Johannesburg, Ekurhuleni and West rand districts,  
 
Gauteng province. The services rendered include mother and child 
 
 health, Internal medicine, Surgical, Neurosciences, Radiology, 
 
 Dental, Allied and Nursing services. The scope of practice of Retinal 
 
 unit at CMJAH include Congenital retinal abnormalities, Vascular, 
 
 Infective, Inflammatory, Traumatic and Degenerative diseases.    
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Macula hole was first described in 1869 and considered 
 
as an untreatable cause of blindness. In 1991, Kelly and 
 
Wendel introduced surgical repair of macula hole and 
 
thousands of people benefited from this surgery with the 
 
             recent anatomic success rate of more than 90%. 1, 2 
 
 
            1.2 Background and Literature Review 
 
            The first MH reported was attributed to trauma and 
 
            observed in young patients. Trauma accounted for 50% of macula 
 
            holes.1 
 
            Eventually, patients with no history of trauma were 
 
            described and by 1970 only 5-9% of MH cases were 
 
            trauma related. 1, 2  
 
            By 1982, 83% of these cases were considered idiopathic and only 
 
           15% were due to trauma.    1, 2 Women in their seventh and eighth 
 
           decade (mean of 65) are commonly affected. 
 
            In a study conducted in Olmsted County, Minnesota, the 
 
            incidence of idiopathic MH was found to be 7.8 persons  
 
            and 8.69 eyes per 100,000 population per year, a 
 
            community largely comprised of Caucasians of the 
 
            northern Europe heritage. 3 
 
           The pathogenesis of MH formation remains incompletely understood.  
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           The process usually evolves over a period of weeks to months.  
 
           Posterior hyaloid detachment begins around the macula, but the 
 
           hyaloid remains adherent to the foveolar center, indicating the action 
 
           of antero-posterior forces.  
 
           This results in intraretinal split evolving into a cystic space 
 
           called a “pseudocyst”, and then to the disruption of the  
 
            outer retinal layer and the opening of the  
 
            foveolar floor, thus constituting full thickness macula 
  
           Hole (FTMH).  
 
           Fifty percent of the pseudocysts may resolve  
 
           spontaneously without any further progression and may 
 
           be seen as an opacity in the prefoveal vitreous, called the 
 
           “operculum”. 4 
 
           Under normal circumstances, the posterior hyaloid is 
 
           firmly attached to the Internal limiting membrane (ILM) 
 
           at the optic disc, fovea as well as at the vascular arcades. As a 
 
            result of the ageing process the vitreous decreases in gel 
 
            like consistency and increases in fluid like consistency, a  
 
            process referred to as syneresis.  
 
           The liquefied vitreous passes into the subhyaloid space,  
 
           causing a subsequent separation of the posterior hyaloid 
 
           from the retina.  
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The posterior vitreous detachment is tethered at the fovea 
 
and enlarges toward the periphery causing antero- 
 
posterior traction on the fovea, leading to foveal 
 
 detachment and subsequent MH formation. 4, 5 
 
Gass and Johnson were the first to classify Idiopathic MH 
 
 into four stages using biomicroscopic observations.  
 
Spontaneous tangential traction of the external part of the  
 
prefoveolar cortical vitreous detaches foveolar,  
 
thereby creating an intraretinal yellow spot  
 
approximately 100-200um in diameter (Stage1). The  
 
yellow color is a result of intraretinal xanthophyll  
 
pigment. The fovea then elevates to the level of the 
 
 surrounding perifoveal retina and transforms the yellow 
  
spot to a small donut-shaped ring (Stage 1B).  
 
             Vision may be between Logmar 0.6-1.0 range and Amsler grid 
 
             together with Watze-Allen test may not reveal any defect.  
 
             Progression to Stage 2 has been reported to occur 50% of the 
 
              time.5,6 The lesion appears to be an eccentric hole due to separation 
 
             of prefoveolar cortex from the one edge of the occult hole. Visual  
 
acuity is usually reduced to Logmar 1.0 and the Watkze-Allen test 
 
 reveals a defect in the slit lamp light beam and with laser aiming 
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 beam test, the patient reports that the light disappears. Stage 2 
 
 holes generally progress to Stage 3 holes, which is defined as 
 
 holes larger than 400um associated with partial vitreo-macula 
 
 separation. A cuff of sub retinal fluid as well as yellow spots are 
 
 seen at the level of the retinal pigment epithelium.1, 5, 6 
 
Stage 3 holes may evolve to Stage 4 holes, which are 
 
 characterized by complete separation of the vitreous 
 
 from the entire macula and optic disc.  
 
A Weiss ring can usually be seen in front of the optic disc in Stage 4 
 
 holes. 
 
 Fellow eyes of patients with macula hole are at low risk 
 
 of developing a macula hole if there are no macula  
 
changes, (1-10% risk of developing macula hole). 1,5,6 
 
Macula holes have been described in association with a  
 
multiplicity of other conditions. High myopia is associated  
 
with progressive and excessive elongation of the globe of  
 
the eye. In a study by Shimada et al in 2006, the incidence of 
 
 macula hole due to high myopia was reported to be 14%. 7 
 
 
Full thickness macula hole (FTMH) may occur rarely in the early 
 
 postoperative period following uncomplicated phacoemulsification, 
 
 and mechanism is unclear.  
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               In a 4 year study by Patterson et al, a stage 2 FTMH was present in 
 
              four of five patients, and a stage 3 FTMH in one of five eyes. 8 MH 
 
              associated with Proliferative diabetic retinopathy (PDR), and Sickle 
 
              cell retinopathy has been reported. MH associated with 
 
               fibrovascular proliferation is an uncommon complication of PDR.9 
 
Macula hole formation following retinal detachment 
 
 surgery have been described by several authors 
 
 previously.  
 
The mechanism of this type of MH formation remains 
 
 unknown. It is thought to be associated with incomplete 
 
 posterior hyaloid detachment at the macula, and the 
 
 presence of epiretinal membrane, which can develop 
 
 after Rhegmatogenous retinal detachment (RRD), or to 
 
 chronic Cystoid macula edema, which can be found  
 
before or after a RRD repair. 10 In a study done by Chan et al, 
 
 three of three myopic eyes developed a macula hole in 
 
 one eye 4-7 weeks after bilateral laser in situ 
 
 keratomileusis or photorefractive keratectomy.11 
 
 
Macula hole formation following rapture of arterial 
 
 macroaneurysm, retinitis pigmentosa, optic pit, 
 
 accidental laser burns, severe hypertensive retinopathy,  
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yag laser capsulotomy has been reported. 12,13,14 
 
Several clinical diagnostic tests are used to aid with the 
 
 diagnosis of macula holes. The Watzke-Allen (W/A),  
 
is performed at the slit lamp by using a macula lens and  
 
placing a narrow vertical slit beam through the fovea, a 
 
positive test is noted when the patient detects a break in 
 
 the beam of light. 
 
The Laser aiming beam test is performed similarly by  
 
using a macula lens and placing the 50um laser- 
 
photocoagulation aiming beam within the lesion; a 
 
 positive test is observed when the patient cannot detect 
 
 the aiming beam within the lesion but is able to detect it 
 
 in the surrounding intact tissue. Most patients report a 
 
 positive Watzke-Allen test, and the use of Laser aiming is 
 
 more sensitive and specific for full thickness macula 
 
 holes. Amsler grid abnormalities are sensitive to macula 
 
 lesions but not specific to macula hole lesions. 1, 6 
 
The modality of choice for the diagnosis of macula holes is 
 
 Optical coherence tomography (OCT). It is currently more 
 
 commonly used because of its accuracy, ease to use, and 
 
 its ability to evaluate the status of vitreomacular  
 
interface.1, 6 
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Surgical management of idiopathic macula holes has 
 
 been described since 1991 with pars plana victrectomy 
 
 (PPV), posterior hyaloid peeling, and air-fluid exchange 
 
 with initial success rate of 58%. 15 Since then, macula hole 
 
 surgery has evolved to include epiretinal membrane 
 
 peeling and internal limiting membrane (ILM) removal,  
 
with or without the use of adjuvants to help in  
 
visualization of the ILM such as indocyanine green dye or 
 
 triamcinolone acetonide. In addition, injection of an 
 
 intravitreal gas bubble with 20% sulfur hexafluoride 
 
 (SF6) or perfluoropropane (C3F8), with or without post- 
 
operative facedown positioning has also been used. These  
 
principles have improved the rate of successful MH 
 
 closure to approximately 90%. 15 
 
Indications for surgery include duration of less than 1 
 
 year, Stage 2 and 3 holes, and visual acuity of less than 
 
 Logmar 0.5. 
 
Previous studies on prognostic factors for primary 
 
 idiopathic macula holes have shown that a smaller 
 
 macula hole size, better initial visual acuity, shorter 
 
 duration of the hole and earlier stage of the macula hole 
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 are associated with better anatomical and visual 
 
 prognosis. 16 
 
In a retrospective series of 40 eyes examined with OCT,  
 
Hoeraf et al as cited by Hans et al (2007) found a closure rate of 
 
 92% for idiopathic holes smaller than 400 microns in diameter 
 
 versus 56% for larger holes. 8 
 
Smiddy et al found that preoperative visual acuity better 
 
 than Logmar 0.60 was the only factor associated with better 
 
 final acuity.2 
 
Peeling of the internal limiting membrane (ILM) helps 
 
              relieve the tangential traction and stimulates glial  
 
proliferation, which aids macula hole closure. The ILM is thin 
 
 and transparent in character, therefore making surgical 
 
 peeling to be technically challenging. Staining of the ILM 
 
 with an adjunct dye makes the procedure faster and 
 
 easier to perform. Several authors have reported the use 
 
 of indocyanine green (ICG) and trypan blue for ILM 
 
 peeling surgery. 
  
              ICG has been found to be toxic to the retina, and 
 
 causes visual field defects, inconsistency of 
 
 postoperative visual acuity and optic atrophy. 17 
 
With trypan blue, ILM peeling can be inconsistent and has 
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 been associated with staining of posterior capsule in 
 
 phakic eyes. Intravitreal triamcinolone acetonide (TA)  
 
has been used to highlight the ILM and allows good view 
 
 of the extent of the ILM peel.  
 
There is limited data on the adverse effects of TA on retinal cells.  
 
The concern is that TA may accumulate in the bottom of the hole 
 
 and may delay wound healing. 17 There is still controversy as to 
 
 whether facedown posturing after macula hole surgery is 
 
 beneficial and, if it is, for how long should it be carried out for.  
 
Facedown position is thought to aid macula hole closure by 
 
 allowing the buoyant force of the intraocular gas bubble, 
 
 which is maximal at the apex of the bubble, to be in 
 
 contact with the macula. The gas bubble keeps the edges 
 
 of the macula dry, prevents the entry of vitreous into the 
 
 hole, and provides the scaffold for glial cell proliferation.  
 
Almeda et al reported a 98% MH closure in 50 eyes who 
 
 underwent pars plana vitrectomy with detachment of the 
 
posterior hyaloid, peeling of the macula ILM, and air-gas 
 
 exchange with SF6 gas for stage 2 and stage 3 idiopathic 
 
 macula holes followed by short duration (3 days) of  
 
 facedown position.15  
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Tadayoni et al as cited by Almeda et al (2012) concluded that small 
 
 idiopathic holes (< 300 micrometer) can be treated without both 
 
 peeling of the ILM and face-down position without ILM peeling and 
 
 without facedown position. Different gases are chosen according to 
 
 the size of macula holes, using longer acting gases for larger hole. 
 
 15,18 Several studies comparing groups with and without 
 
 facedown posturing found no statistical differences in 
 
 either anatomical or functional results. 19  
 
Nadal et al as cited by Muselier et al (2010) reported that the use of 
 
 a long lasting gas such as C3F8 keeps the macula dry in all positions 
 
 except the supine, during at least the first week, without the need 
 
 of postoperative face down position.20 
 
The most common complication of vitreo-retinal surgery 
 
 in phakic eyes is nuclear sclerotic cataract progression,  
 
(75-95%), which frequently requires surgical treatment 
 
 within the 2 years following macula hole surgery. Lens 
 
 opacity makes ILM even more difficult. 
  
There is still controversy of the timing of cataract surgery in 
 
 patients with macula holes.  
 
Both combined (cataract extraction and MH repair 
 
 at the same time) and consecutive (MH repair then  
 
cataract surgery at a later stage) are safe and effective 
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 methods to treat macula holes and cataract with similar  
 
functional and anatomic results in both procedures.  
 
Combined surgery has numerous advantages, such as:  
 
patient not having to come back for the second operation;  
 
if small retinal tears appear in the anterior retina, they are 
 
 easily identified and treated and, retinal visualization is  
 
optimal during vitreous surgery. Combined surgery also 
 
 has the advantage of being cost effective and results in 
 
 faster visual recovery.21 
 
Other complications of macula hole surgery include 
 
 retinal tears in up to 20%, retinal detachment in 
 
 approximately 2% in previous studies and formation of 
 
 peripheral visual defects as a result of fluid-air exchange  
 
which can be minimized by avoiding dehydration of the 
 
 retina.1 Enlargement of macula holes, macula hole 
 
 reopening, retinal pigment epithelium loss under the 
 
 hole, postoperative formation of epiretinal membranes 
 
 and endophthalmitis have also been reported. 22,  
 
ILM peeling significantly decreases the incidence of a 
 
 reopening of a macular hole. The incidence of reopening 
 
 of macula hole is 0%-8.6% in eyes where the ILM was  
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peeled off and 2%-16% in eyes in which the ILM was not 
 
 peeled off. 22 
 
1.3 Problem statement 
 
In view of the fact that very little has been written on 
 
 macula holes (MH) in African patients, the aim of this  
 
 study is to describe and analyse clinical features and 
 
 surgical outcome of macula holes in patients operated at 
 
 CMJAH. 
 
             1.4 Study aim 
                
              The aim of the study was to evaluate the clinical and 
  
              surgical outcome of patients with MH treated at CMJAH 
  
              
                1.5 Study objectives 
 
 The objective was to describe and analyse the 
 
 demographic and clinical features of patients with MH 
 
 treated at CMJAH 
 
 To describe and analyse visual and anatomical 
 
 outcome of patients MH treated at CMJAH 
             
              CHAPTER 2: Research methodology 
 
2. Study methods 
 
2.1 Design: 
 
 A retrospective review of preoperative and postoperative 
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 findings of patients who underwent macula hole 
 
 surgery, from 01 January 2008 (when CMJAH acquired an 
 
 OCT imaging instrument) to 30 October 2012, at 
 
 Charlotte Maxeke Johannesburg Hospital. Data collection 
 
 will be from clinical records of the patients. 
 
The clinical collected included: (see Appendix A) 
 
 Preoperative and postoperative visual acuity 
 
 Duration of the macula hole 
 
 Macula hole size on OCT 
 
 Preoperative photoreceptor variability on OCT 
 
 Postoperative visual acuity (1 month, 3 months and 6 
 
 months) 
 
 Surgical technique 
 
 Days of postoperative face-down posturing 
       
 
             2.2 Inclusion criteria: 
 
 Patients with macula holes treated at CMJAH 
 
 
 Preoperative and postoperative OCT imaging 
 
 records available 
 
 Preoperative and postoperative visual acuity 
 
      records available 
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             2.3 Exclusion criteria: 
 
 Preoperative and postoperative OCT imaging 
 
       records unavailable 
 
 Preoperative and postoperative visual acuity 
 
       records unavailable 
 
            2.4 Sample size: 
             
              All patients with macula hole treated at CMJAH between 
  
              01 January 2008 and 30 October 2012 
 
           2.5 Outcome measures: 
 
            Primary: A change in visual acuity at three months 
 
             following surgery. In patients with multiple 
 
             surgeries, the three months following the last  
 
             surgical procedure. 
              
            Secondary:  Anatomic closure of the macula hole on OCT 
           
             imaging at three months following surgery.                          
                                                                 
            2.6 Data collection 
              
             The patient’s names and hospital numbers were kept 
 
             confidential and did not appear on the data collection sheet. 
 
             This sheet only had the study subject number and this 
 
             study number and the link to the hospital number was 
 
              kept separate. 
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             A data collection sheet (Appendix A) contained the 
 
             following information: 
 
a) The eye that has undergone macula hole surgery 
  
b) Underlying systemic condition 
 
c) The age and sex of the patient were specified 
 
d) The date of the macula hole surgery was noted 
 
e) The pre and post operative visual acuity were recorded 
 
f) The post operative follow- up dates (1 month, 3 months 
 
                and 6 months) were recorded 
 
g) Qualitative and quantitative features on OCT imaging 
  
h) Surgical technique 
 
2.7 Data analysis 
 
The data collected was captured on an Excel spreadsheet 
 
2.8 Statistical considerations 
 
Descriptive statistics was used to analyse demographic 
 
 and clinical data.  
 
2.9 Ethical clearance 
 
The study commenced once the ethics clearance was 
 
 obtained from the Human Research Ethics committee. 
 
2.10 Funding 
 
Photocopies of the data capture sheets were provided by 
 
 the division of Ophthalmology. 
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2.11 Limitations 
 
The nature of the study is retrospective, thus data 
 
 available depended on the information that was found in 
 
 patient files. 
 
2.12 Authorship 
 
Dr DL Mailane 
 
Dr A Makgotloe 
 
2.13 Reporting plans 
 
1. Presented at a departmental academic meeting 
 
2. Present at a local congress 
 
3. Article submission to a journal 
 
4. Masters in medicine report writing 
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CHAPTER 3: Results 
 
3.1 Overview of study participants 
 
 
                
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1 
 
Of the 80 patients, only 39 patients (49%) were analysed because of the 
missing hospital records of the other 41 patients (51%).  
 
 
 
Total PPV theatre records 
identified 
(01 January 2008 – 30 October 
2012) 
N = 780 
 
Macula hole theatre cases done 
n = 80 
Excluded Other 
Posterior 
segment cases 
n = 700 
Subjects Records found 
n = 39 
Subjects 
excluded 
(no records) 
n = 41 
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3.2 Patient demographics 
 
3.2.1. Age 
 
 
Figure 3.2 
 
The bar chart illustrates the age distribution of the study 
 
 population. 
 
 Of the 39 records, the average age of macula hole patients is 
 
 65 years and the mean age of 63 years (range 36-86). Sixteen (16) of the 
 
 39 patients (41%) were between the ages of 66-75 years. 
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3.2.2 Gender 
 
 
 
 Figure 3.3 
 
 
Pie chart demonstrating the distribution of gender of the  
 
study participants. 
 
 Of the 39 patients, 19 patients were males (49%) and 20 
 
 patients were females (51%).  
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3.2.3 Race 
 
 
 
Figure 3.4 Pie chart describing race distribution of the 
 
 study population. Twenty three (23) patients were black (59%), 13 
 
 patients white (33%) and 3 patients Indian (8%) 
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3.2 Clinical features of study patients 
 
 
Subject Age 
(years) 
Gender Duration of 
symptoms 
(months) 
Eye 
Left/Right 
Pre-
operative  
VA (log 
Mar) 
1 51 Female 12 Left 1.0 
2 67 Female 12 Left 1.0 
3 47 Female 6 Left 1.0 
4 76 Male 3 Right 1.3 
5 67 Female 6 Right 1.3 
6 55 Female 3 Right 1.0 
7 44 Male 9 Right 1.0 
8 70 Male 3 Left 1.0 
9 71 Female 12 Left 1.3 
10 67 Male 12 Left 1.3 
11 42 Male 12 Right 2.0 
12 64 Male 12 Right 1.0 
13 36 Male 12 Right 0.6 
14 49 Male 2 Right 1.0 
15 51 Male 5 Left 0.8 
16 66 Female 12 Left 1.0 
17 75 Female 12 Left 0.8 
18 80 Male 12 Right 0.8 
19 62 Male 6 Left 0.6 
20 74 Male 12 Right 1.3 
21 58 Male 7 Right 1.3 
22 57 Male 18 Left 1.0 
23 50 Male 36 Left 1.3 
24 77 Female 1 Left 0.6 
25 71 Female 24 Left 1.3 
26 67 Male 4 Right 1.3 
27 71 Female 5 Right 1.3 
28 65 Female 12 Right 1.3 
29 51 Female 48 Left 1.3 
30 63 Female 12 Right 1.3 
31 68 Female 3 Right 0.6 
32 72 Female 6 Right 1.3 
33 86 Male 12 Right 0.8 
34 75 Male 3 Left 1.0 
35 77 Female 56 Left 1.3 
36 59 Female 12 Left 1.0 
37 62 Male 12 Right 1.0 
38 65 Female 3 Right 1.0 
39 69 Female 6 Right 1.0 
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Table 1 demonstrates preoperative features of the subjects 
 
All the 39 patients had pre-op VA records available. Of the number, 20 
 
 were female and 19 were male patients. The average duration of 
 
 symptoms was 12 months (range, 1 - 56 months) and the median pre- 
 
 operative visual acuity was Logmar1.0 (n=15).  
 
 
3.3 Visual and anatomical outcome at 1 month  
 
Subject Pre-operative 
VA (logMar) 
Post-operative 
VA (logMar) 
Anatomical 
outcome at 1 
month 
1 1.0 1.0 Closed 
2 1.0 1.0 Closed 
4 1.3 1.3 Closed 
5 1.3 1.3 Closed 
9 1.3 1.0 Open 
10 2.0 1.0 Closed 
11 1.0 1.3 Open 
12 1.0 1.3 Closed 
13 0.5 0.8 Closed 
15 0.8 1.3 Open 
18 1.0 1.0 Open 
20 1.3 1.3 Open 
25 1.3 1.3 Closed 
26 1.3 1.3 Closed 
27 1.3 1.3 Closed 
28 1.3 2.0 Open 
31 0.5 0.5 Open 
32 1.3 1.3 Open 
34 2.0 2.0 Closed 
36 1.0 0.6 Closed 
37 1.0 1.0 Closed 
38 1.0 1.0 Closed 
39 1.0 1.0 Closed 
 
Table 2 illustrates the clinical features of patients up to 1 months 
 
 follow up. 
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Best corrected visual acuity (logMar) at 1 month 
 
 Only 23 subjects had pre-operative VA, post-operative VA and macula hole 
 
 anatomical records. The median BCVA at 1 month was logMar1.3 (n=10). 
 
 15 of 23 patients (65%) had the same BCVA i.e. no change, 3 of 2 patients 
 
 (13%) had improvement in visual acuity and 5 of 23 patients (22%) had 
 
 decrease of BCVA at 1 month post operative period.  
 
 
Anatomical macula hole outcome at 1 month 
 
Fifteen (15) of 23 (65%) patients had macula holes closed, and 8 of 23 
 
 (35%) had open macula hole at the1month post- operative period.  
 
3.4 Visual and anatomical outcome at 3 months 
 
 
Subject Age 
(Years
) 
Gender Duration of 
symptoms 
(Months) 
Eye 
Right/Left 
 Pre-op  
VA 
(logMar) 
Pre-op 
IHD 
(um) 
Pre-
op 
BHD 
(um) 
3monthP
ost-op 
VA 
(logMar) 
Macula 
hole at 
3 
months 
5 67 Female 6 Right 1.30 698 873 1.0 Closed 
8 70 Male 3 Left 1.0 486 698 1.0 Closed 
14 49 Male 2 Right 1.0 163 786 1.0 Closed 
15 51 Male 5 Left 0.80 536 785 1.30 Open 
21 58 Male 7 Right 1.30 424 723 1.0 Closed 
37 62 Male 12 Right 1.0 849 1023 1.0 Closed 
39 69 Female 6 Right 1.0 187 474 1.0 Closed 
 
Table 3 illustrates the clinical features of patients up to 3 months 
 follow up.  
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Of the 39 patients, only 7 patients had pre-operative VA, post-operative VA, 
 
 pre-operative macula hole diameters and macula hole anatomical clinical 
 
 outcome records at 3 months due to missing data from the patient’s files. 
 
Best corrected visual acuity 
 
Four (4) of 7 patients (58%) had no change in BCVA at the 3 month follow 
 
 up period.  
 
Two (2) of 7 patients (28%) had an improvement and 1 of 7 patients 
 
 (14%) had worsening of visual acuity. The median gain in BCVA between 
 
 pre-operative data and the 1 month to 3 month visit (n= 2) was 1 line, 
 
 Logmar1.0.  
 
Anatomical macula hole at 3 months 
 
Seven (7) of 39 patients had pre-operative and post-operative Ocular 
 
 coherence tomography (OCT) records. The median pre-operative inner 
 
 hole diameter was 377um, and the basal hole diameter was 766um. Six (6) 
 
 of 7 patients (86%) had closed macula holes at 3month post-operative 
 
 period and only 1 patient had an open macula hole (14%).  
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CHAPTER 4: Discussion 
 
In this work, we reviewed a total of 80 patients who had macula 
 
 hole surgery performed between the period of January 2008 –  
 
30 October 2012. Of the 80 patients who underwent surgery, 
 
 only 39 records were found from the filing system and the rest  
 
of the patient records, (41) were not found.  
 
A total of 7 patients were fully analyzed because 32 patients of this 
 
 group did not meet the inclusion criteria as mentioned in the study 
 
 methods, i.e. availability of pre-operative visual acuity, post- 
 
operative visual acuity, pre-operative OCT and post-operative 
 
 OCT measurements. 
 
The reason for lack of a significant number of records was due 
  
to poor or loss to patient follow up following surgery and other 
 
 subsequent visits to the clinic. 
  
Poor record keeping from the hospital personnel, both medical and 
 
 administrative, i.e. lack of detailed clinical notes also led to lack of all 
 
 required information from the hospital files, resulting in a large number 
 
 of subjects been excluded from the study. The old record 
 
 keeping system at our hospital which combined all the clinical 
 
 notes from all the other departments i.e. medical and surgical 
 
 disciplines, make finding relevant information an extremely 
 
 difficult process. 
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In an observational study by Sliwa et al performed at Chris Hani 
 
 Baragwanath hospital in Soweto, South Africa, looking at 
 
 different lipid profiles according to ethnicity in the heart of 
 
 Soweto Study, lipid profiles of 2182 patents were examined.  
 
Data was recorded in a Cardiology clinical registry where 
 
 detailed structural and functional, fasting lipid profiles of all 
 
 patients presenting in their Cardiology unit were documented.  
 
90% records with detailed information could be obtained 
 
 suggesting that having such a system in place utilized in a 
 
 department was very beneficial despite the absence of the new 
 
 electronic medical record system23. 
 
 
Mberi et al reported an almost similar finding in a retrospective 
 
 observational study performed at one of the Medunsa National 
 
 Pharmaco-vigilance centers, Determinants of loss to follow up 
 
 in patients on anti-retroviral treatment, South Africa, 2004- 
 
2012.24 
 
 Out of 595 patients, 139 (23%) were lost to follow up at 
 
 21 months citing reasons like employment commitments and 
 
 lack of family support.24 
 
 Another study related or explaining large numbers of study participant 
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 loss was published from a Kwazulu- Natal University, South Africa, by 
 
 Chetty et al, a retrospective study of Human deficiency virus transmission, 
 
 mortality and loss to follow up among infants in the first 18 
 
 months of life in a prevention of mother-to-child transmission  
 
programme. Of the 260 infants enrolled 155 (59.6%) remained 
 
 in the care at McCord center beyond 28 weeks, 1infant died in less than 28 
 
 days, 34 infants were lost to follow up within 7 days and 60 infants were 
 
 lost to follow up by 6 months. Routine data from antenatal history,  
 
care and delivery was collected from Prevention from Mother to  
 
Child care obtained from patient clinical records. In the above  
 
two South African studies, loss to follow up was between 23%-41%. 
 
Our study had a greater loss of follow up to treatment (82% of  
 
files). This had a large and negative impact on the final findings 
 
 due to the small number of patients and this affected making any  
 
 generalizations on our study.25 
 
The mean age of enrolled patients in our study was 63 years (range 
 
 36-86), where more than 2/3 were between the ages of 65-75 years. 
 
 This was found to be consistent with the study by Garcia- 
 
Loyana et al where the mean age of their population study was 
 
 65 years. 23 The distribution between males and females was almost  
 
equal in our study, which is in contrast to a study by Mc Cannel 
 
 et al where male to female ratio was (1:2.4). 3 The Eye disease 
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 case control study reported an increase of fibrinogen levels 
 
 (>2.95g/L) as a risk factor, whereas the use of oestrogen as a 
 
 protective factor.  
 
However, a larger number of patients and longer period of our follow up 
 
 would have provided an almost similar finding as previously shown in  
 
 other studies similar to ours. 1, 3 
 
The reason for the almost equal gender distribution in our work 
 
 could be attributed to the lack of sufficient records found.  
 
Amongst the 80 patients that were identified from theatre  
 
records, majority were females. Our study also demonstrated a 
 
 greater percentage of African patients (59%) as compared to 
 
 other ethnic groups, (33% of Caucasians and 8% Indian patients).  
 
This finding is consistent with population based ethnic groups  
 
in Central Johannesburg where Charlotte-Maxeke Johannesburg  
 
hospital is located.  
 
A large population based study of idiopathic macula holes reported a rate 
 
 of 7.8% persons and 8.7% eyes per 100,000 populations / year in Olmsted 
 
 County Minnesota, a community largely composed of Caucasians (90%) of  
 
Northern European heritage, had different racial distribution compared  
 
to our study. 3 This explains and supports different racial distributions in 
 
 majority of studies. 
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All 39 patients had the duration of visual loss and preoperative visual 
 
 acuity records available. The average duration of visual loss symptoms 
 
 was 12 months (range, 1-56 months). 
  
The reasons for late presentation in our study group 
 
 compared to other study groups could be due to poor socio- 
 
economic status present in South Africa as a developing country,  
 
poor access to eye specialist centers and coexisting medical 
 
 health related conditions patients may have. 
 
 
 In a study by Passemad et al on long-term outcomes of idiopathic macula 
 
 hole surgery, in Burgundy, France, the mean duration of visual loss was  
 
7,6 months (range, 1-24 months). 72 eyes (53,3%) had visual  
 
symptoms for less than 6 months and in 29 eyes (21.5%) was 
 
 unclear due to lack of data on patient’s clinical files. 19 
 
 In the European vitreo-retinal society (EVRS) macula hole study 
 
 published in 2013, 407 patients were followed up over 1 year 
 
 by 140 retinal specialists in 28 countries, the average duration 
 
 of symptoms was 4 weeks which resulted in a good surgical 
 
 outcome of 92% of patients.  This is higher than most published data.25  
 
The mean pre-operative BCVA was (Logmar1.0), n=15 in our study group. 
 
 
 
 This finding is almost similar to a study by Huang et al, a study of 67 
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 patients with idiopathic macula hole, the median BCVA at presentation 
 
 was logMar 0.60 in lamellar holes and in full thickness macula holes, 
 
 range (logMar 0.2-1.3). 26 
 
Twenty three (23) patients had postoperative BCVA and macula hole 
 
 anatomical records available at 1 month. The remainder of the  
 
subjects were lost to follow-up as described previously as no  
 
further record of their visits could be found. The mean BCVA at  
 
1 month was 1.3, (n=10). Fifteen (15) of 23 patients (65%) had the same 
 
 BCVA i.e. no change, 3 patients (13%) had an increase in BCVA 
 
 and 5 patients (22%) had a decrease in BCVA 1month 
 
 postoperative period. The BCVA slightly worsened from the  
 
median of (Logmar1.0) preoperative to median of (Logmar1.3) 
 
 at 1 month postop.  
 
We believe that the results could have been different if there was no 
 
 limitation of data retrieval and most importantly longer follow up period 
 
 of the surgical outcome of our study patients. Chawla et al reported long- 
 
term structural and functional outcomes following macula hole surgery of 
 
 patients over the mean follow up period of 36 months. Best corrected  
 
visual acuity (BCVA) continued to improve from the median of 
 
 Logmar0.5 at 4 months to Logmar0.4 at 6 months. 
 
 
 In the EVRS Macula study, low preoperative BCVA was associated with 
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 improvement in final BCVA, whereas high preoperative BCVA resulted in 
 
 poor final outcome.  Chawla et al study concluded that BCVA continues to  
 
improve beyond 4 months to 6 months after macula hole surgery.  
 
This information helps clinicians counsel patients appropriately and  
 
help explain cases of unsatisfactory visual improvement after  
 
surgery. 23  
 
Furthermore, looking at the postoperative anatomical macula hole  
 
 outcome in our study, fifteen (15) of 23 patients (65%) 
 
 had closed macula holes, 8 patients (35%) had open macula holes  
 
at 1month postoperative period. This information appears 
 
 contradictory to our visual outcomes where the BCVA  
 
declined slightly during 1 month postoperative period. Some patients 
 
 with closed holes had scar formation on the macula area which 
 
 explains poor visual acuity despite successful holes closure. This 
 
 information was recorded in the patient clinical records at  
 
subsequent clinic visits.  
 
The EVRS macula hole study showed a linear increase of closed macula 
 
 hole and improvement of BCVA at the end of 12 months. 25 
 
At 3 months postoperative follow up, only 7 patients had 
 
 preoperative and postoperative BCVA, together with  
 
preoperative and postoperative OCT records. The rest of the 
 
 patients were excluded from the final analysis of our study due 
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 to lack of this vital information. Four (4) of 7 patients (58%) had no  
 
change in BCVA at 3 month postoperative visit and remained at  
 
logMar1.0. 
 
Two of 7 (28%) patients had an improvement in BCVA of 1 line (logMar1.3  
 
to 1.0) and 1 of 7patients (14%) had worsening of visual acuity 
 
 (logmar 0.8 decreased to logMar 1.3). The median gain in BCVA between 
 
 preoperative and postoperative period was logMar1.0, n=2, which was 
 
 approximately 1line improvement.  
 
Of the 7 fully analysed subjects, the median preoperative inner 
 
 hole diameter was 377um and the basal hole diameter was 
 
 766um. 6 of 7 patients (86%) had closed macula holes at 3  
 
month post operative visit and only 1 patient (14%) had an open macula  
 
 hole. 2 patients had preoperative macula hole size of less than  
 
400um, and the rest of the patient’s macula hole size was 
 
 greater than 400um. Our study shows that larger macula holes still benefit 
  
from macula hole surgery and this was similar to findings in the 
 
 EVRS macula study where larger holes showed great structural  
 
and functional outcome especially when operated early i.e.  
 
within 4 weeks. 
  
Our final patients all presented later than 4 weeks, however, good visual  
 
and structural improvements were achieved. 
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Limitations of our study was that a large number of files were lost to 
 
 follow up in the system. However, larger numbers and 
 
 availability of records could show similar results as other 
 
 published studies. 25,26,27  
 
The EVRS macula hole study is a recent large multi-centered publication 
 
 with contribution from 140 retinal specialists from 28 countries, where 
 
 patients had same preoperative variables that we had in our study, that is 
 
 surgical techniques including usage of dye, internal limiting membrane 
 
 peeling, tamponading agents and postoperative position. It must be 
 
 realized that all those European countries are developed and 
 
 have or employ electronic record systems.  
 
The retrospective nature of our study also had a negative impact on the 
 
availability of information. Our hospital is in the process of improving 
 
 record keeping methods and this also contributed to some files being 
 
 unavailable too. Studies with a longer period of follow up are 
 
 required to look at the long-term surgical outcome in our very 
 
 own hospitals which has shown continued improvement for up 
 
 to a period of 1 year in the mentioned studies. 
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CHAPTER 5: Conclusion 
  
In conclusion, our study provides evidence that macula hole 
 
 surgery achieves to achieve good functional and anatomical 
 
 results, with the highest success rate published in the EVRS 
 
 macula hole study 2013 as 92%. A study with larger numbers 
 
 and longer duration of study would be beneficial to support our 
 
 findings. Improvement of hospital and departmental record 
 
 keeping systems will be of great help not only for future studies,  
 
but also for patient management, medico-legal and academic reasons. 
 
This might be achieved by establishing departments own record keeping, 
 
 Investing in electronic filing system with good back up system and also  
 
encouraging and instilling the culture of good record keeping amongst  
 
colleagues in a department. 
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Data collection sheet 
 
The Clinical outcome of Macula Hole Surgery Done at Charlotte 
 
Maxeke Johannesburg Academic Hospital 
 
 
Date of operation:                              Participant number: 
 
Age: 
 
Sex:        Male               Female                         
  
Eye operated:              Right                           Left                 
 
Underlying systemic condition: 
 
 
Visual acuity:                Preoperative            Postoperative 
 
Duration of macula hole: 
 
Preoperative photoreceptor viability on OCT: 
 
Macula hole size on OCT:         Preoperative      Postoperative   
 
 
Postoperative follow-up visits 
 
1 month:                                 VA                 OCT               Slitlamp 
 
3 months: 
 
6 months: 
 
OCT features: 
 
Qualitative: 
 
Quantitative: 
 
Surgical technique: 
 
            PVD induction                                        Yes/No 
 
Staining of ILM                                       Nil/ICG/TB/TA 
 
ILM peel                                                   Yes/No 
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Air-fluid exchange                                Yes/No 
 
Tamponade                                             Air/SF6/C3F8/Silicon oil  
                            
Postoperative face-down                    Yes/No 
 
Facedown duration (days) 
 
Other procedures 
 
Cataract operation                                 Yes/No 
 
Retinotomy                                               Yes/No 
 
Retinal detachment repair                   Yes/No 
 
Complications: 
 
Follow-up: 
 
 
 Month 1 Month 3 
BCVA   
Lens status   
Metamorphopsia   
IOP   
Macular   
OCT Qualitative   
OCT Quantitative   
Complications   
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